Aircraft engineers for Qantas have lost a challenge to a ruling that the airline had no “genuine choice” when it stood them down in March 2020 during the COVID-19 pandemic.
Nine ‘fishing’ for defence in barrister’s defamation case over cavoodle custody battle, court hears
Mercedes-Benz to argue Takata airbags recall was invalid
KPMG liquidators can’t dodge examination over handling of Jewel of India sale
Insurer on hook for doctor’s costs in breast implant class action
Class action’s bid for ‘invasive’ search of Merivale’s payroll data fails
Judge says vaccine lawsuit against Monash Health was not ‘doomed to fail’
ACCC flags competition concerns over $1.2B Port of Geelong acquisition
High Court won’t hear ALP members’ challenge to federal takeover of election
Securing ACCC nod for patent settlement with rivals no easy task, first draft decision shows
The competition regulator has proposed to deny authorisation for a patent settlement that sought to permit early entry of generic drugs. Whether the companies involved will be able to quell the ACCC’s concerns remains to be seen, but what is clear is that future authorisation applications will contend with significant forensic challenges, writes Corrs Chambers Westgarth’s Odette Gourley, Richard Flitcroft, David Fixler and Ian Reynolds.